Relevant enterprises in Wenjiang District, Sichuan Province have paid attention. In 2022, Wenjiang District has started to apply for supporting support for scientific research projects, drug R&D subsidies (support year 2021), and medical device R&D subsidies (support year 2021). We have sorted out the relevant information for you. If you meet the conditions and want to declare or have any questions, please call the editor.
Wenjiang District "2022-01 [2019] 01-32-02-Supporting Support for Scientific Research Projects" declaration items :
2022-01〔2019〕01-32-02-support for scientific research projects
2022-02〔2019〕55-09-01-Drug research and development subsidy (support year 2021)
2022-02〔2019〕55-09-02-Medical device research and development subsidies (support year 2021)
Wenjiang District "2022-01 [2019] 01-32-02- Supporting Support for Scientific Research Projects" application process :
Please log in to the "Policy Declaration" column of "Wenjiang Public Information Network", or directly log in to the "Policy Declaration" column of "Wenjiang District Smart Enterprise Service Platform", and declare according to the project details.
Wenjiang District "2022-01 [2019] 01-32-02- Supporting Support for Scientific Research Projects" declaration time :
The centralized application period for projects is from September 21, 2022 to October 10, 2022.
Wenjiang District " 2022-01〔2019〕01-32-02-Supporting Support for Scientific Research Projects ' applicant subject
Private enterprises or institutions with industrial and commercial registration, tax payment, and statistical statements located in Wenjiang District, with independent legal personality, sound financial system, and independent accounting.
Wenjiang District " 2022-01 [2019] 01-32-02-Supporting support for scientific research projects " application conditions
- The application project is a science and technology project that has been supported by the national ministries and commissions, provincial and municipal science and technology departments.
- Obtained a national scientific research project approved by the national ministries and commissions.
- Provincial-level scientific research projects approved by the Sichuan Provincial Department of Science and Technology: key research and development plans (major scientific and technological projects), scientific and technological achievements transfer and transformation guidance plans (scientific and technological achievements transformation, innovative products), technological innovation projects, new coronavirus scientific and technological research and other key research and development projects.
3. Municipal scientific research projects approved by the Chengdu Science and Technology Bureau: key industry research and development support plans (technical innovation research and development projects, major technological innovation projects, special projects for epidemic prevention and steady growth, major technological application demonstration projects, key new product research and development subsidies, major innovations products) and other key R&D projects.
(2) The relevant funding funds from the higher level have been received, and the funds received from the national, provincial and municipal scientific research projects will be received between January 1, 2021 and December 31, 2022.
Wenjiang District " 2022-01 [2019] 01-32-02- Supporting Support for Scientific Research Projects " Application Subsidy Criteria
Wenjiang District " 2022-01 [2019] 01-32-02-Supporting support for scientific research projects " application materials
- Proof of scientific research projects funded by national ministries and commissions, provincial and municipal science and technology departments.
- A copy of the receipt certificate of national, provincial and municipal appropriation funds.
- Letter of Commitment and Statement of Authenticity of Materials.
Wenjiang District " 2022-02〔2019〕55-09-01-drug research and development subsidy (support year 2021) " applicant subject
An enterprise that develops pharmaceutical R&D and industrialization in Wenjiang District.
Wenjiang District " 2022-02 [2019] 55-09-01-drug research and development subsidy (support year 2021) " application conditions
- For applications for R&D subsidies in the clinical trial stage of drugs, the applicants for drug clinical trials are limited to enterprises in the area (if the applicant is inconsistent with the subject of R&D expenses, if it is verified that they are related enterprises in the area, they can be regarded as the same entity to apply; For varieties jointly developed by two or more units within the country, the first completion unit shall submit an application).
2. The enterprise's drug clinical trial approval or drug registration approval will be obtained between January 1, 2021 and December 31, 2021.
Wenjiang District " 2022-02〔2019〕55-09-01-drug research and development subsidy (support year 2021) " application award standard
Wenjiang District " 2022-02〔2019〕55-09-01-Drug R&D Subsidy (support year 2021) " application materials
- Letter of Commitment to Integrity Declaration.
- Last year's "Enterprise Income Tax Annual Return" signed and sealed by the enterprise.
- Last year's financial audit report with anti-counterfeit QR code and special audit report on single-variety R&D investment (must have anti-counterfeit QR code).
- Those who enter the phase I clinical trial need to provide the phase I clinical trial notification, the certificate on the drug clinical trial registration and information disclosure platform on the official website of the Center for Drug Evaluation of the State Drug Administration, or other valid certification materials; those who enter the phase II clinical trial need Provide the phase II clinical trial notification, the certificate on the drug clinical trial registration and information disclosure platform on the official website of the Center for Drug Evaluation of the State Drug Administration, the phase I clinical summary report or the end certificate report (sensitive information can be hidden), or other valid Evidence materials; those entering phase III clinical trials need to provide a phase III clinical trial notification, a certificate on the drug clinical trial registration and information disclosure platform on the official website of the Center for Drug Evaluation of the State Drug Administration, a phase II clinical summary report or an end certificate report ( Sensitive information can be concealed), or other valid certification materials; if entering the drug registration application acceptance stage, a drug registration application acceptance notice, phase II or phase III clinical summary report or end certification report (sensitive information can be concealed), or Other valid proof materials.
- Those who apply for the fifth stage of policy subsidies need to provide a detailed list of single-variety sales, sales contracts, tax invoices, and bill summary sheets. The order of relevant bills should be consistent with the bill summary table, etc. and sales settlement or sales settlement of the variety held by the holder of the drug marketing authorization in Wenzhou), and a special audit report on the sales of a single variety with an anti-counterfeit QR code (must have an anti-counterfeit QR code).
- Commitment letter for production and sales settlement or sales settlement in Wenzhou.
Applicants for "2022-02 [2019] 55-09-02-Medical Device R&D Subsidy (2021 Support Year)" in Wenjiang District
An enterprise that develops medical device research and development and industrialization in Wenjiang District.
Wenjiang District "2022-02 [2019] 55-09-02-Medical Device R&D Subsidy (2021 Support Year)" Application Conditions
- Obtained the registration certificate of Class III and non-diagnostic Class II medical devices for the first time.
- The time for obtaining the enterprise medical device registration certificate is between January 1, 2021 and December 31, 2021.
Wenjiang District "2022-02〔2019〕55-09-02-Medical Device R&D Subsidy (Support Year 2021)" Application Award Subsidy
Wenjiang District "2022-02〔2019〕55-09-02-Medical Device R&D Subsidy (support year 2021)" application materials
- Letter of Commitment to Integrity Declaration.
2. Last year's "Enterprise Income Tax Annual Return" signed and sealed by the enterprise.
3. Last year's financial audit report with anti-counterfeit QR code and special audit report on single-variety R&D investment (must have anti-counterfeit QR code).
4. Innovative medical device materials: medical device registration certificate, application form for special review of innovative medical devices submitted to the national or provincial business authority, and relevant certification materials issued by the national or provincial business authority for agreeing to special review. General medical device materials: medical device registration certificate (first registration) and corresponding medical device production license and medical device production product registration form.
5. The special audit report (must have anti-counterfeit QR code) for the accumulative sales revenue of a single product exceeding 10 million yuan with the anti-counterfeit QR code, as well as the detailed list of product sales, sales contract, tax invoice and bill summary in the certificate, and the relevant bills should be with The order of the bill summary table shall be consistent (provide the cumulative sales revenue of the products in the certificate exceeding 10 million and the production and sales settlement or sales settlement of the varieties held by the medical device registrant in Wenzhou).
6. Commitment letter for production and sales settlement or sales settlement in Wenzhou.
Well, the finishing is over here, and the declaration time is about to end! If you are still unclear about the company, please contact the editor! In addition, you can also consult the editor for free to answer and guide you about intellectual property rights, project declaration, technology transfer, business incubation, financing listing and other technical projects!
